Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 2/2002

01-03-2002

Projecting SEER cancer survival rates to the US: an ecological regression approach

Authors: Angela Mariotto, Riccardo Capocaccia, Arduino Verdecchia, Andrea Micheli, Eric J. Feuer, Linda Pickle, Limin X. Clegg

Published in: Cancer Causes & Control | Issue 2/2002

Login to get access
Metadata
Title
Projecting SEER cancer survival rates to the US: an ecological regression approach
Authors
Angela Mariotto
Riccardo Capocaccia
Arduino Verdecchia
Andrea Micheli
Eric J. Feuer
Linda Pickle
Limin X. Clegg
Publication date
01-03-2002
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 2/2002
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1023/A:1014380323037

Other articles of this Issue 2/2002

Cancer Causes & Control 2/2002 Go to the issue

OriginalPaper

Sinonasal cancer and occupational exposures: a pooled analysis of 12 case–control studies

OriginalPaper

Breast cancer risk after childbirth in young women with family history (Denmark)

OriginalPaper

Galactose-1-phosphate uridyl transferase (GALT) genotype and phenotype, galactose consumption, and the risk of borderline and invasive ovarian cancer (United States)

OriginalPaper

Breast and cervical cancer screening and disease incidence and stage in New Mexico

OriginalPaper

Paternal preconceptional irradiation, population mixing and solid tumorsin the children of radiation workers (England)

OriginalPaper

A prospective study of life satisfaction, neuroticism and breast cancer risk (Finland)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits